MiMedx Group, Inc. (MDXG) stock
MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3040% below fair value
$3.18+0.00 (0.00%)
Close on Nov 17, 2026Market cap $464.04MP/E –Yield –
MiMedx EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
MiMedx's EV/EBITDA was 41.7× on Nov 11, 2026, against 16.6× a year earlier. Over the last 5 years it ranged from 5.5× to 290.7×, with a median of 19.6×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 41.7× | +25.4 |
| 2025 | Dec 31, 2025 | 16.3× | −4.9 |
| 2024 | Dec 31, 2024 | 21.2× | −8.8 |
| 2023 | Dec 29, 2023 | 30.0× | +21.0 |
| 2019 | Jan 31, 2019 | 9.0× | +3.2 |
| 2018 | Dec 31, 2018 | 5.8× | −96.0 |
| 2017 | Dec 29, 2017 | 101.8× | +47.4 |
| 2016 | Dec 30, 2016 | 54.5× | +8.6 |
| 2015 | Dec 31, 2015 | 45.8× | – |
See a number that looks wrong?